Monitor for any subsequent dilution or capital raises, as reverse splits often precede equity offerings. The stock remains speculative given the company's small market cap and clinical-stage status.
Price Chart
Executive Summary
Plus Therapeutics (PSTV) announced it has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share, following a one-for-twenty-five reverse stock split implemented on April 2, 2026. Nasdaq confirmed compliance after the stock closed above $1.00 for 10 consecutive business days from April 6 to April 17, 2026.
Key Facts
- Plus Therapeutics regained compliance with Nasdaq's $1.00 minimum bid price rule.
- Compliance was achieved after a one-for-twenty-five reverse stock split effective April 2, 2026.
- Nasdaq confirmed compliance based on 10 consecutive business days (April 6–17, 2026) of closing prices at or above $1.00.
- The company was previously at risk of delisting due to non-compliance.
Financial Impact
No direct financial impact; the reverse split reduced share count but did not alter the company's market value or fundamentals.
Risk Factors
- Potential for future non-compliance if share price declines again.
- Reverse split may signal financial distress and could negatively impact investor sentiment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-165205 |
| Document: pstv-ex99_1.htm | 0001193125-26-165205 |
| Document: 0001193125-26-165205-index-headers.html | 0001193125-26-165205 |
| Document: 0001193125-26-165205-index.html | 0001193125-26-165205 |
| Document: 0001193125-26-165205.txt | 0001193125-26-165205 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 21, 2026 14w ago | Press Release | $3.92 | awaiting T+20 | — | — |
Jun 30, 2026 17w ago | Press Release | $4.37 $3.73 | ▼ −14.65% | ▼ −13.62% | — |
Jun 8, 2026 20w ago | EFFECT | $5.53 $4.05 | ▲ +26.76% | ▲ +28.39% | — |
Jun 5, 2026 20w ago | S-3/A | $5.41 $4.05 | ▼ −25.14% | ▼ −27.00% | — |
May 19, 2026 23w ago | Press Release | $5.83 $4.31 | ▼ −26.07% | ▼ −27.06% | — |
May 15, 2026 23w ago | Press Release | $5.84 $4.57 | ▲ +21.75% | ▲ +23.33% | — |
May 8, 2026 24w ago | Press Release | $6.12 $5.41 | ▼ −11.60% | ▼ −11.62% | — |
Apr 28, 2026 26w ago | Press Release | $5.95 $6.60 | ▲ +10.92% | ▲ +5.46% | — |
Apr 21, 2026 27w ago | 8-K | $7.14 $5.84 | ▼ −18.21% | ▼ −23.12% | — |
Apr 9, 2026 28w ago | 8-K | $3.92 $6.00 | ▲ +53.06% | ▲ +45.49% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers